Abstract |
L- asparaginase (ASNase) enzyme has limited therapeutic use due to its poor pharmacokinetics and immunogenicity. To overcome these obstacles, we immobilized ASNase in biocompatible poly hydroxypropyl methacrylamide (P( HPMA))-based nanogels simply formed through the host-guest inclusion complex of ASNase-conjugated random copolymer of HPMA and polyethylene glycol (PEG) acrylate (P( HPMA- MPEGA)) and α- cyclodextrin dimer (bisCD) using cystamine as a linker. The effects of bisCD and polymer concentrations on particle size, gelation time, and recovery of enzyme activity were investigated. The ASNase-conjugated bisCD nanogels were discrete, homogeneous, and spherical with a mean projected diameter of 148 ± 41 nm. ASNase immobilized in the bisCD nanogels caused cytotoxicity on HL-60 cell line with IC50 of 3 IU/ml. In-vivo rat study revealed that the immobilized ASNase reduced the enzyme antigenicity and resulted in 8.1 folds longer circulation half-life than the native enzyme. Conclusively, immobilization of ASNase in P( HPMA- MPEGA) and bisCD supramolecular nanogels could enhance the therapeutic value of ASNase in cancer chemotherapy.
|
Authors | Maryam Monajati, Ali Mohammad Tamaddon, Samira Sadat Abolmaali, Gholamhossein Yousefi, Sanaz Javanmardi, Sedigheh Borandeh, Reza Heidari, Negar Azarpira, Rassoul Dinarvand |
Journal | Colloids and surfaces. B, Biointerfaces
(Colloids Surf B Biointerfaces)
Vol. 225
Pg. 113234
(May 2023)
ISSN: 1873-4367 [Electronic] Netherlands |
PMID | 36934612
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023. Published by Elsevier B.V. |
Chemical References |
- Asparaginase
- Polyethylene Glycols
- Nanogels
- hydroxypropyl methacrylate
- alpha-Cyclodextrins
- Antineoplastic Agents
|
Topics |
- Rats
- Animals
- Asparaginase
(metabolism, therapeutic use)
- Polyethylene Glycols
(pharmacokinetics)
- Nanogels
- alpha-Cyclodextrins
- Antineoplastic Agents
(pharmacokinetics)
|